Stay updated with breaking news from Rosty Raykov. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Good morning, ladies and gentlemen, and welcome to Fennec Pharmaceuticals Third Quarter 2023 Earnings and Corporate Update Conference Call.
~ PEDMARK® Net Product Revenue of $6.5 Million, a 96% Increase Compared to Second Quarter ~ ~ Strong Commercial Uptake Underscoring Significant Unmet Medical Need ~ ~ Received Approval in October...
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q2 2023 Earnings Call Transcript August 6, 2023 Operator: Good morning, ladies and gentlemen and welcome to the Fennec Pharmaceuticals Second Quarter 2023 Earnings and Corporate Update Conference Call. [Operator Instructions] As a reminder, today’s conference call is being recorded. Now, I would like to turn the conference over to Fennec’s […]
RESEARCH TRIANGLE PARK, N.C., June 12, 2023 -- Fennec Pharmaceuticals Inc. today announced that the nominees listed in the management proxy circular dated April 24, 2023 for the Annual General... | June 12, 2023
06.06.2023 - Pedmarqsi is the First and Only Approved Therapy in the European Union for Reducing the Risk of Cisplatin-induced Hearing Loss (Ototoxicity) in Pediatric Patients with Localized, Non-metastatic Solid TumorsRESEARCH TRIANGLE PARK, N.C., June 06, ... Seite 1